VEGFA and nonpapillary renal cell carcinoma: As for VEGFA expression, there were no significant differences in survival time of ccRCC and chRCC patients based on VEGFA mRNA levels, however, pRCC patients with low VEGFA expression had a significantly higher (p=0.0013) survival rate (more than half of patients are still alive) compared to patients with high VEGFA expression (mst 87.5 months) (Figure 4).